Mode
Text Size
Log in / Sign up

Spinal tweak lowers inflammation in MS patients

Share
Spinal tweak lowers inflammation in MS patients
Photo by Becky Geist / Unsplash

Imagine waking up with a stiff neck and wondering if a simple adjustment could help your body fight back. For people with multiple sclerosis, the immune system often attacks the nerves by mistake. This study asks if a specific type of spinal manipulation can calm that chaos.

Multiple sclerosis affects millions of people worldwide. The disease damages the protective coating around nerves, making it hard for signals to travel. This leads to weakness, numbness, and fatigue.

Current treatments focus on slowing the disease or managing symptoms. But many patients still struggle with pain and inflammation. Doctors need new tools to help these patients feel better every day.

The surprising shift

For years, we thought spinal adjustments only helped back pain. We did not know if they could change how the immune system works. This pilot study changed that view. It looked at people with relapsing-remitting multiple sclerosis.

But here is the twist. The team did not just push on the spine. They combined the adjustment with trigger point therapy. This means they also pressed on tight knots in the muscles before the spinal tweak.

Think of your immune system like a busy traffic jam. Too many emergency vehicles (inflammatory cells) are stuck in the wrong places. This causes damage to the roads (nerves).

Spinal manipulation acts like a traffic cop. It might clear the jam and let the emergency vehicles go home. The study measured specific chemicals in the blood that signal inflammation. These are the markers that tell us if the "traffic jam" is getting worse or better.

The researchers studied 21 people with multiple sclerosis. They split the group into two teams. One team got the real spinal manipulation and muscle therapy. The other team got a fake version, known as sham treatment.

Both groups visited the clinic twice a week for four weeks. Blood was drawn at five different times. This included right before the treatment, 20 minutes after, and two hours after. The team checked over 20 different markers in the blood.

The results were promising for the right reasons. Six specific chemicals that cause inflammation dropped significantly in the treatment group. These drops happened at multiple times after the session.

The effect was strong enough to be noticed clearly. In plain English, the spinal tweak helped turn down the volume on the body's inflammatory alarm. This suggests the treatment could help stop the immune system from attacking nerves as hard.

But there is a catch

The study also looked at other measures. Did people walk better? Did they feel less pain? The answer was mixed. Some improvements were small. Most changes did not reach the level needed to be considered a major clinical win yet.

This doesn't mean this treatment is available yet.

That is a crucial point to remember. This was a small pilot study. It was designed to see if the idea works before a big trial. The results are exciting, but they are not the final word.

Scientists believe these findings are a solid foundation. They suggest that future large studies should focus on these specific inflammatory markers. The combination of spinal work and muscle therapy seems to be the key.

If you have multiple sclerosis, talk to your doctor about your options. This study shows that spinal manipulation might be a helpful addition to your routine. It is not a replacement for your current medicine.

However, do not try to find a practitioner who promises a cure. Look for a licensed chiropractor who works with your medical team. They can check if this approach fits your specific needs.

This study had some limits. It only included 21 people. That is a small number. The changes in walking and pain were not huge. More research is needed to prove these benefits last longer.

The next step is a larger trial. Researchers will test this method on hundreds of patients. They will also study the timing of the treatment more closely. If the big study works, this could become a standard part of care. Until then, it remains an exciting area of research.

Share
More on Multiple Sclerosis